ENTITY
Torrent Pharmaceuticals

Torrent Pharmaceuticals (TRP IN)

121
Analysis
Health CareIndia
Torrent Pharmaceuticals Ltd. manufactures bulk drugs and pharmaceutical formulations. The Company's formulations include cardio-vascular, psychotropic and anti-biotic drugs while its bulk drugs include atenolol, ciprofloxacin and norfloxacin. Torrent Pharmaceuticals has wholly owned subsidiaries in several regulated and less regulated international markets.
more
02 Nov 2024 09:58Broker

Torrent Pharma: Steady Growth and Margin Visibility Outlook Intact. Maintain ADD

The recent ~9% stock price correction for Torrent Pharma (TRP) was due to a ~3% stake sale by the promoter group (Mehta Family)

Logo
310 Views
Share
28 Oct 2024 23:12

Torrent Pharmaceuticals (TRP IN): Domestic Business Drives Q2 Result; Margin Expansion to Continue

​Torrent Pharmaceuticals reported 17% YoY increase in net profit on 9% YoY revenue growth and expanding EBITDA margin in Q2FY25. Going ahead, the...

Logo
265 Views
Share
19 Jan 2025 08:30

APAC Healthcare Weekly (Jan 19)- Samsung Biologics, Daiichi Sankyo, Eisai, Sun Pharma, Biocon

APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...

Logo
323 Views
Share
04 Jul 2024 05:25Broker

Torrent Pharma: Focus on branded generics and profitability. Maintain ADD

In its FY24 annual report, Torrent Pharma (TRP) has highlighted strategic themes that align with its short, medium and long-term goals

Logo
218 Views
Share
bearishMankind Pharma
12 Dec 2023 08:34

Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release

The two pre-IPO investors have launched a block to sell around US$591m worth of Mankind Pharma shares. Since the lockup on the shares expired not...

Logo
606 Views
Share
x